Hepatology: Princess Margaret Hospital

Total Score People Score Events Score
38 33 6
Date Event Presentation Speakers
April 10, 2015 Asian Oncology Summit 2015 Improving the efficiency of cancer drug development: the importance of mechanistic translational studies in early clinical trials Ian Tannock
Drug resistance and the tumour microenvironment: inhibition of autophagy as a strategy to improve clinical benefit Ian Tannock
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity The Development of Predictive Biomarkers in Clinical Trials in the Context of Potential Tumor Heterogeneity Lillian L. Siu
May 31, 2013 ASCO Annual Meeting 2013 Career Choices: Options in Academia, Practice, Industry, and Government Lillian L. Siu
Lung Cancer in 2013: State of the Art Frances Shepherd
Special Session Ian Tannock
Special Sessions Lillian L. Siu
January 22, 2010 2010 Gastrointestinal Cancers Symposium Medical oncologist Lillian L. Siu
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Metastatic Pancreatic Cancer: How to Select the Best Options Malcolm J Moore
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management Welcome from PMH Mary K. Gospodarowicz
Welcome from ISC Ronald Feld
Predictive biomarkers in targeted therapy: Lessons learned Ming-Sound Tsao
Session I: Targeted Therapies I Ming-Sound Tsao
Going beneath the surface: Novel agents for downstream signaling targets David W. Hedley
Targeted therapies for CNS malignancies Warren P. Mason
Surgical debate: Is there a role for surgery in stage IIIA NSCLC? Gail E. Darling
Session III: Gastrointestinal malignancies Eric X. Chen
Targeted therapy of pancreas Malcolm J Moore
Liver radiotherapy Laura A. Dawson
Welcome to day two Ronald Feld
PET/CT for GI tumors Ur Metser
Session V: Genitourinary Neil Fleshner, Srikala Sridhar
Image guided therapy in prostate cancer John Trachtenberg
Targeted radiotherapy in urologic cancer Cynthia Ménard
Session VI: Targeted Therapies II Mary K. Gospodarowicz
Measuring residual DNA damage in situ as a clinical biomarker of molecular target inhibition in radiotherapy and chemotherapy trials Robert G Bristow
Challenges in the design of early phase clinical trials evaluating combinations of radiotherapy and molecularly targeted therapies Anthony Brade
Session VII: Malignant Hematology Michael Crump, Hans A. Messner
Update on chelation therapy Karen W.L. Yee
Management of patients with CML: Beyond imatinib Jeffrey H. Lipton
Management of the elderly with acute myeloid leukemia Joseph Brandwein
Targeted therapy for lymphoma Michael Crump
Targeted therapy in the elderly Lillian L. Siu
Welcome to day three Ronald Feld
Pharmacogenomic markers in lung cancer Geoffrey Liu
Session X: Breast Cancer Natasha Leighl, David Warr
Targeted therapy: Targeting tumors or targeting patients? Christine Simmons
Session XI: Supportive Care: Managing Toxicities of Targeted Agents Janice Wright
Safety and efficacy of rituximab abbreviated infusion Tracy Nagy
Session XII: Challenging Cases Ronald Feld, Joseph Mikhael
Bladder cancer: Adjuvant versus neoadjuvant therapies Srikala Sridhar
Lymphoma: Maintenance therapy Vishal Kukreti
Locally advanced lung cancer: Combined modality therapy Andrea Bezjak, Natasha Leighl
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.